Adient (ADNT) PT Lowered to $67 at Buckingham Research

Go back to Adient (ADNT) PT Lowered to $67 at Buckingham Research

Adient (ADNT) PT Lowered to $75 at Morgan Stanley

February 1, 2018 7:37 AM EST

Morgan Stanley lowered its price target on Adient (NYSE: ADNT) to $75.00 (from $89.00) while maintaining a Overweight rating.

... More

Adient (ADNT) PT Lowered to $75 at Wells Fargo

January 30, 2018 8:34 AM EST

Wells Fargo lowered its price target on Adient (NYSE: ADNT) to $75.00 (from $85.00) while maintaining a Outperform rating.

... More

Adient (ADNT) PT Lowered to $73 at Baird

January 30, 2018 8:27 AM EST

Baird lowered its price target on Adient (NYSE: ADNT) to $73.00 (from $81.00) while maintaining a Neutral rating.

... More

Adient (ADNT) PT Lowered to $87 at UBS

January 30, 2018 8:21 AM EST

UBS lowered its price target on Adient (NYSE: ADNT) to $87.00 (from $92.00) while maintaining a Buy rating.

... More

Adient (ADNT) PT Lowered to $69 at JPMorgan

January 30, 2018 7:30 AM EST

JPMorgan lowered its price target on Adient (NYSE: ADNT) to $69.00 (from $74.00) while maintaining a Underweight rating.

... More

Adient (ADNT) PT Lowered to $64 at Guggenheim, 'It Could Get Worse Before It Gets Better'

January 30, 2018 6:13 AM EST

Guggenheim lowered its price target on Adient (NYSE: ADNT) to $64.00 (from $90.00) while maintaining a Neutral rating.

... More

Adient (ADNT) PT Lowered to $69 at Barclays

January 30, 2018 4:22 AM EST

Barclays lowered its price target on Adient (NYSE: ADNT) to $69.00 (from $71.00) while maintaining a Equalweight rating.

... More